A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
Condition(s):Malignant Peripheral Nerve Sheath Tumors (MPNST)Last Updated:March 1, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Malignant Peripheral Nerve Sheath Tumors (MPNST)Last Updated:March 1, 2024Recruiting
Condition(s):Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic SyndromesLast Updated:August 4, 2023Enrolling by invitation
Condition(s):Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Acute Myeloid LeukemiaLast Updated:February 18, 2020Completed
Condition(s):Acute Myeloid LeukemiaLast Updated:January 8, 2024Recruiting
Condition(s):Neurological CancerLast Updated:September 9, 2020Recruiting
Condition(s):MDS; AMLLast Updated:September 13, 2023Active, not recruiting
Condition(s):Acute Myeloid Leukemia; Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory Myelodysplastic SyndromeLast Updated:July 7, 2020Withdrawn
Condition(s):Acute Myeloid LeukemiaLast Updated:March 13, 2024Recruiting
Condition(s):Metastatic Breast Cancer; Triple Negative Breast Cancer; Hormone Receptor Positive TumorLast Updated:March 22, 2024Completed
Condition(s):Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Acute Myeloid LeukemiaLast Updated:September 5, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.